• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Labgenius Ltd.

Headquarters: London, United Kingdom
Year Founded: 2012
Status: Private

BioCentury | Apr 4, 2025
Management Tracks

Ex-Dyne team members reconvene at Crescent

Plus: New staff at Neurocrine, Xaira and Dark Blue; Oz confirmed at CMS
BioCentury | Jan 11, 2025
Management Tracks

Faces in new places ahead of JPM: Rubin joining Guggenheim

Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
BioCentury | Jan 10, 2025
Management Tracks

Odyssey hires Jason Haas as CFO

Plus: CMO changes at Centessa, Lifordi, Rapport and Gemma, and updates from Peptone, Labgenius, Mitorx and more
BioCentury | Sep 12, 2024
Management Tracks

Ovid promotes Alexander to COO

Plus: Tyra hires Warner as CMO and updates from Senisca, Closed Loop, NanoSyrinx and more
BioCentury | Sep 6, 2023
Management Tracks

Thaysen leaving Agilent to become CEO of Illumina

Plus: Josh Schimmer, Eric Schmidt join Cantor 
BioCentury | Dec 1, 2021
Management Tracks

Grauer becomes CMO at Federation Bio

Plus: LabGenius, 23andMe, Vifor, Immunovia, Forma and more
BioCentury | Jul 15, 2021
Regulation

July 15 Quick Takes: FDA panel rebuffs FibroGen CKD program; plus PAQ, Galapagos, Adlai Nortye and Ablynx-LabGenius

In light of concerns over roxadustat’s cardiovascular safety risks, FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 13-1 against approval of the oral HIF-PH inhibitor to
Items per page:
1 - 8 of 8